Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Martin, Elferink"'
Autor:
Alessio Marcozzi, Myrthe Jager, Martin Elferink, Roy Straver, Joost H. van Ginkel, Boris Peltenburg, Li-Ting Chen, Ivo Renkens, Joyce van Kuik, Chris Terhaard, Remco de Bree, Lot A. Devriese, Stefan M. Willems, Wigard P. Kloosterman, Jeroen de Ridder
Publikováno v:
npj Genomic Medicine, Vol 6, Iss 1, Pp 1-11 (2021)
Abstract Levels of circulating tumor DNA (ctDNA) in liquid biopsies may serve as a sensitive biomarker for real-time, minimally-invasive tumor diagnostics and monitoring. However, detecting ctDNA is challenging, as much fewer than 5% of the cell-free
Externí odkaz:
https://doaj.org/article/876ba2e504214507ada4be457cb69876
Autor:
Alessio Marcozzi, Myrthe Jager, Martin Elferink, Roy Straver, Joost H. van Ginkel, Boris Peltenburg, Li-Ting Chen, Ivo Renkens, Joyce van Kuik, Chris Terhaard, Remco de Bree, Lot A. Devriese, Stefan M. Willems, Wigard P. Kloosterman, Jeroen de Ridder
Publikováno v:
npj Genomic Medicine, Vol 8, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/c14ffc21d524455a986206f100c1542e
Publikováno v:
Genetics in Medicine, 24(6), 1306-1315. ELSEVIER SCIENCE INC
PURPOSE: Few studies have systematically analyzed the structure and content of laboratory exome sequencing reports from the same patient. METHODS: We merged 8 variants from patients into "normal" exomes to create virtual patient-parent trios. We prov
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 23(3)
Existing research suggests that while some laboratories report variants of uncertain significance, unsolicited findings (UF), and/or secondary findings (SF) when performing exome sequencing, others do not.To investigate reporting differences, we crea
Autor:
Heleen, Schuring-Blom, Klaske, Lichtenbelt, Karin, van Galen, Martin, Elferink, Marjan, Weiss, Joris Robert, Vermeesch, Lieve, Page-Christiaens
Publikováno v:
Prenatal diagnosis. 36(8)